150 related articles for article (PubMed ID: 9511043)
1. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.
Tomizawa H; Tateda K; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 1998 Jan; 41(1):103-6. PubMed ID: 9511043
[TBL] [Abstract][Full Text] [Related]
2. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Frémaux A; Sissia G; Geslin P
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
Saravolatz L; Manzor O; Check C; Pawlak J; Belian B
J Antimicrob Chemother; 2001 Jun; 47(6):875-7. PubMed ID: 11389122
[TBL] [Abstract][Full Text] [Related]
5. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.
Miyazaki S; Domon H; Tateda K; Ohno A; Ishii Y; Matsumoto T; Furuya N; Yamaguchi K
Antimicrob Agents Chemother; 1997 Nov; 41(11):2582-5. PubMed ID: 9371375
[TBL] [Abstract][Full Text] [Related]
7. Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
Hershberger E; Rybak MJ
Antimicrob Agents Chemother; 2000 Mar; 44(3):598-601. PubMed ID: 10681324
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.
Nicodemo AC; Mendes CM; Oplustil CP; Sinto S
Braz J Infect Dis; 2001 Apr; 5(2):50-2. PubMed ID: 11493408
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of six fluoroquinolones against invasive Streptococcus pneumoniae isolated from 1996 to 2001 in Taiwan.
Chen JY; Fung CP; Wang CC; Chu ML; Siu LK
Microb Drug Resist; 2003; 9(2):211-7. PubMed ID: 12820807
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe).
Odland BA; Jones RN; Verhoef J; Fluit A; Beach ML
Diagn Microbiol Infect Dis; 1999 Aug; 34(4):315-20. PubMed ID: 10459483
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.
Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
Clin Ther; 1998; 20(6):1179-90. PubMed ID: 9916611
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal resistance in the UK.
Goldsmith CE; Moore JE; Murphy PG
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():11-8. PubMed ID: 9484868
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
[TBL] [Abstract][Full Text] [Related]
14. Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Niki Y; Tamada S; Nakabayashi M; Soejima R
Drugs; 1995; 49 Suppl 2():420-2. PubMed ID: 8549385
[No Abstract] [Full Text] [Related]
15. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
White RL; Enzweiler KA; Friedrich LV; Wagner D; Hoban D; Bosso JA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):207-17. PubMed ID: 12106954
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
Park HS; Oh SH; Kim HS; Choi DR; Kwak JH
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869677
[TBL] [Abstract][Full Text] [Related]
17. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.
Ho PL; Yung RW; Tsang DN; Que TL; Ho M; Seto WH; Ng TK; Yam WC; Ng WW
J Antimicrob Chemother; 2001 Nov; 48(5):659-65. PubMed ID: 11679555
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of DW286 against Streptococcus pneumoniae.
Park HS; Jung SJ; Choi DR; Kwak JH
Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.
Jones RN; Johnson DM; Erwin ME; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):91-8. PubMed ID: 10354857
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK
J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
